Company intelligence / Profile preview

Stamford Pharmaceuticals

Greenwich, Connecticut, United Statesstamfordpharmaceuticals.com ↗
Ownership
Private
Development stage
Other
01

Overview

Stamford Pharmaceuticals has demonstrated positive Phase 2 results for its lead gene therapy candidate SP‑002 in combination with vismodegib for multi-lesional and locally advanced basal cell carcinoma. The studies showed safety and efficacy signals, supporting further development into Phase 3 trials. The company is also advancing additional programs targeting other cutaneous cancers and solid tumors using its proprietary vector-drug conjugate platform[10][6][1].

Therapeutic areas
Oncology
Modalities
Gene therapyAdenovirus-based gene therapySmall molecule-drug conjugateVector-drug conjugateSmall molecule (for combination therapies)
Industry
Biotech
02

Drug pipeline

4 assets

SP-002

2

3 more assets in the full pipeline.

03

Partnerships

Signed term-sheet with a European pharma company for US/EU rights to BCC/SCC indicationsSeries A led by Tenmile Ventures and Prevail Partners

Beyond the preview

Go deeper on Stamford Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stamford Pharmaceuticals.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call